Prescription Drug News and Research

RSS

House reform outline includes public insurance option

"House Democrats released the outline of their health care reform bill Friday - a proposal that would create a public insurance option, expand Medicaid, and require employers to provide coverage or pay a tax," Politico reports. "The outline did not include details on how Democrats would pay for the plan."

21 Jun 2009

PEPFAR and IDUs; economic crisis and health; human-rights and pharmaceutical companies

Although PEPFAR has helped to provide "antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than US$18 billion on the continent" it has failed to reach "thousands of injecting drug users in PEPFAR countries in Africa, many of whom have HIV," according to the authors of a recent comment in the journal Lancet.

21 Jun 2009

Timeline for health legislation slips as HELP, Finance Committees hit snags

Senators delayed work Wednesday on one health care reform bill and hit partisan roadblocks on another as key lawmakers insisted they are still on track to have a bill on the floor by the middle of summer, The Washington Post reports.

18 Jun 2009

A long ‘to-do’ list for FDA Chief Hamburg

The Washington Post details Food and Drug Administration Commissioner Margaret Hamburg’s to-do list, noting that during her brief tenure the agency has announced nearly-daily warnings about various consumer products and created an internal task force to recommend ways to release more information about FDA decisions and policies.

18 Jun 2009

Senate Health Committee to begin reform mark up today, finance to follow next week

Senate Democrats are scrambling to reduce the price tag of reform proposals, which initial estimates place at $1.6 trillion, The Wall Street Journal reports.

18 Jun 2009

Medical schools improve conflict of interest policies, but widespread problems remain

According to the latest ratings of two watchdog groups, medical schools are "improving their conflict-of-interest policies to police their ties with drug and medical-device makers. But more than half the schools still have inadequate policies or no policies at all," the Wall Street Journal's Health Blog reports.

18 Jun 2009

House bill may target drugmakers' advertising tax breaks

Rep. Charles Rangel, D-N.Y., says the House Ways and Means Committee may seek to raise money for health reform by imposing a $37 billion tax on drugmaker's advertisements, Bloomberg reports: "As lawmakers seek ways to pay for a health-care overhaul, 'one thing that's not off the table is you can pick up $37 billion knocking out the deduction for advertising' for prescription drugs,'" Rangel said. The idea is among several proposals by Democratic legislators to raise reform money (Donmoyer, 6/16).

18 Jun 2009

HIV Medicine Association supports public plan option to ensure patients' needs are met

As Congress drafts health care reform legislation, HIV clinicians urge lawmakers to include a public plan option to ensure affordable access to comprehensive care for HIV patients - nearly 30 percent of whom have no insurance. The HIV Medicine Association (HIVMA) believes that a public plan option can help offer everyone the chance to benefit from early and reliable access to lifesaving HIV care and treatment.

16 Jun 2009

GlaxoSmithKline to cut some drug costs in emerging markets

GlaxoSmithKline (GSK) plans to decrease the prices of many of its leading medicines in emerging markets following the success of a pilot program in the Philippines, Andrew Witty, GSK's chief executive, said, Financial Times reports. Witty said the price cuts are part of an effort to diversify and expand globally.

15 Jun 2009

Drugstores group sues Delaware over Medicaid cutbacks

Walgreen Co.'s member organization in Delaware has "filed a suit against the state to put a stop to Medicaid rate cuts" just one week after "Walgreens announced it will stop filling prescriptions of brand-name medications for patients on Medicaid" in Delaware, the News Journal reports.

13 Jun 2009

India to promote drugs in Africa after fake Chinese drugs 'made in India' seized

India launched a project to promote its $10.7 billion pharmaceutical industry in Africa after fake drugs labeled "Made in India," but with actual origins in China were seized on the continent, IANS/Hindu reports.

13 Jun 2009

Democrat bill, FTC examine ways to drive down health care costs

A bill introduced Wednesday in the House would create an artificial joints database to root out bad practices and unnecessary surgeries, The New York Times reports.

11 Jun 2009

Democrats target a dozen GOP senators in quest for health reform deal

Senate Finance Committee Chairman Max Baucus and other Democratic leaders are targeting more than a dozen moderate and conservative Republicans as they pursue a bipartisan deal to extend health care coverage to nearly 46 million uninsured Americans.

11 Jun 2009

FDA approves injectable Ibuprofen

The U.S. Food and Drug Administration today approved Caldolor, the first injectable dosage form of the common pain medication ibuprofen, to treat pain and fever.

11 Jun 2009

Baucus: 'effectiveness' part of health-care bill, could reduce health xosts

"Senate Finance Chairman Max Baucus, D-Mont., said Tuesday he expects Senate health-care legislation will include provisions encouraging doctors to compare drugs and therapies for their effectiveness," Dow Jones Newswires reports.

10 Jun 2009

Medical industry showers Department of Defense with free travel

The health care industry funded "8,700 trips by Department of Defense personnel" from 1998 to 2007, at a cost of more than $10 million, the Center for Public Integrity reports.

10 Jun 2009

Seniors seek help with Medicare's 'doughnut hole'

Senior and elderly advocate groups are calling on Congress to get rid of the "doughnut hole" in Medicare's drug benefit as part of the larger efforts to reform health care, according to The Dallas Morning News.

9 Jun 2009

Baucus: Comparative effectiveness will be in health reform bill

Senate Finance Committee Chairman Max Baucus, D-Mont., says that a comprehensive health reform package - due out from his committee within the next week or two - will include plans to compare the effectiveness of drugs and other medical treatments so Americans can answer the question: "What are we getting for our money?"

9 Jun 2009

Economic downturn pushes cost of medicines up, pharmacists lobby for reform role

"Even with the Medicare drug benefit, even with the prevalence of low-cost generics, even with loss-leader discounting by big chains, many Americans still find themselves unable to afford the prescription medications that manage their life-threatening conditions," The New York Times reports.

4 Jun 2009

FDA moves towards greater openness

The Associated Press reports that FDA Commissioner Margaret Hamburg "announced Tuesday she has created a task force to make recommendations on how the agency can release more information in such areas as drug evaluation and enforcement matters. She wants a report in six months."

3 Jun 2009